DIA
INSM icon

Denver Investment Advisors’s Insmed INSM Stock Holding History

Denver Investment Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-29,259
Closed -$387K – 477
2016
Q4 		$387K Buy
+29,259
New +$399K 0.02% 383
2015
Q2 		– Sell
-117,550
Closed -$2.44M – 579
2015
Q1 		$2.44M Buy
+117,550
New +$2.07M 0.08% 249

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Denver Investment Advisors's INSM Position: Q1 2017 in Review

Denver Investment Advisors sold out of Insmed (INSM) in Q1 2017, closing a stake of 29,259 shares — an estimated $387K sold.

Denver Investment Advisors first reported a position in INSM in Q1 2015 and held it in 2 quarters. The position peaked at $2.44M in Q1 2015. 100 funds tracked by Wall St. Rank hold INSM as of Q1 2017.

  • Denver Investment Advisors reported no remaining Insmed position as of Q1 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 29,259 Insmed shares in Q1 2017, an estimated $387K.
  • Denver Investment Advisors first reported a position in Insmed in Q1 2015 and held it in 2 quarters.
  • Denver Investment Advisors's Insmed position peaked at $2.44M in Q1 2015.
  • 100 funds tracked by Wall St. Rank held Insmed as of Q1 2017.

Based on Denver Investment Advisors's 13F filing for Q1 2017, filed 5 May 2017.